monovalent antifibrinogen antibody fragments. J Clin Invest 1975; 55:1259-68 Total bilirubin 125 smol/l (7-3 mg 100 ml), ALP 0-9 0-6 --0-3 196 U;1, AST 185 U/1, ALT 59 UI, creatinine 111 ,umol/l (1-3 mg/100 ml) *Normal ranges: total bilirubin 2-26 gmol/l (0-1-1-5 mg/100 ml), alkaline phosphatase (ALP) 45-125 U/1, aspartate aminotransferase (AST) 7-40 U/l, alanine aminotransferase (ALT) 7-40 U/1, creatinine RLmol/l (0-8-1-5 mgj100 ml).
Conversion: SI to traditional units-Digoxin: 1 nmol'l 0-8 ng 'ml.
patients had impaired renal function or were receiving digoxin. The table summarises the clinical diagnosis, medications, and relevant laboratory values in these patients. Digoxin was measured in plasma by both radioimmunoassay (two different manufacturers: NML Laboratories Inc, Dallas, and Abbott Laboratories, Chicago) and fluorescence polarisation immunoassay (TDX, Abbott Laboratories). The lower limit of detection by radioimmunoassay is 0-3 nmol/l (0-23 ng/ml) and by fluorescence polarisation 0-3 nmol/l. Bilirubin does not interfere with either method. The normal (therapeutic) range for digoxin in our laboratory is 1-0-2-6 nmol/l (0-8-2-0 ng/ml).
The table shows the values for plasma digoxin by both methods. The presence of digoxin like immunoreactive substance (measured by radioimmunoassay) occurred in all the patients. There was no apparent correlation between the degree of hyperbilirubinaemia and the concentration of digoxin like immunoreactive substance measured by radioimmunoassay.
Comment
The presence of an endogenous substance causing falsely raised plasma digoxin concentrations has been reported in premature infants and patients with renal failure.2 3 Our study shows that this digoxin like immunoreactive substance is present in the plasma of patients with liver disease. The magnitude of the increase in digoxin like immunoreactive substance is enough to compromise the usefulness of a measured value of digoxin in the clinical management of a patient with liver disease who requires digoxin.
The nature and physiological importance of the substance are unknown. Its presence in bile and the absence of correlation between the concentration of the substance in plasma and hyperbilirubinaemia probably indicate that other substances-for example, bile acids -may be interfering with the digoxin assay. Against this assumption, however, is the presence of digoxin like immunoreactive substance in premature infants and patients with renal failure,2 3 conditions in which bile acid concentrations are normal. Endogenous digoxin like immunoreactive substance has been reported in animals,4 5 and it has been suggested that it may have a role in controlling extracellular fluid volume.
Whatever the nature of digoxin like irnmunoreactive substance, its presence in plasma may pose serious problems in interpreting plasma digoxin concentrations, which are usually maintained within a narrow therapeutic range. Our observations indicate that fluorescence polarisation does not measure digoxin like immunoreactive substance and seems to be the method of choice for digoxin measurements in liver disease. 
Leishmania braziliensis braziliensis infection of the nipple
We have not been able to trace a published reference to leishmaniasis of the nipple. We recently saw two cases in the region of Tres Bravos, Bahia State, Brazil. Leishmania braziliensis braziliensis was isolated from this site in a 37 year old man. A lactating mother also had a nipple granuloma. The same organism was isolated from her 3 month old child, who developed a lesion on the upper lip.
Case histories
Case 1-A 37 year old man from Coxa da Onca farm, Jiquiriq4, had a large ulcer (3X7 cm) of seven months' duration over the xiphisternum. Three months later three small granulomas under a centimetre in size appeared on the left forehead. At the same time his right nipple became hard and painful. There was no other history of skin ulceration, and no oronasal lesion was present. The leishmanin skin test reaction was strongly positive at 48 hours (15 mm). The indirect immunofluorescence antibody test for leishmaniasis using an amastigote antigen of L mexicana amazonensis reached a titre of 1/80. Triturated biopsy material from the breast lesion inoculated into a hamster resulted in the isolation of a parasite characterised as L braziliensis braziliensis by immunofluorescence using specific monoclonal antibody. Treatment with three courses of meglumine antimonate (Glucantime) 28 mg/kg daily for 10 days resulted in resolution of all lesions except the nipple. Despite a further two courses of the drug this lesion persisted. One year after he was first seen the nipple granuloma was larger and associated with lymphadenopathy. As he refused admission to hospital for more intensive treatment we decided to excise the nipple, although the histological picture was inflammatory granuloma with no evidence of malignancy. Initial biopsy showed some necrosis and poorly organised granuloma in the nipple. The surgical specimen, however, contained mature granuloma rich in Langhans giant cells. There was no sign of healing and the inflammation was widely distributed in the mammary tissue. Pseudoepitheliomatous hyperplasia was present but there was no evidence of malignant change.
Case 2-A 35 year old woman from Serra do Homen farm, Corte da Pedra, consulted us because of a three week history of swelling of the lip of her 3 month old child (figure). Biopsy was not permitted but needling of the upper lip showed amastigotes in the Giemsa stained smear. Five other small granulomas were present on the head (two), trunk (two), and right leg. Biopsy of the leg lesion showed an exudative cellular infiltrate with scanty parasites. The organism recovered by hamster inoculation from this lesion was typed as L braziliensis braziliensis. The leishmanin skin test result was negative but a 1/320 dilution of sera yielded leishmanial fluorescent antibodies. Examination of the mother disclosed multiple lesions. The largest (30 x 1-5 cm) on the left arm had been present for four months and had closed after application of battery acid, although the border was still active. Biopsy of this border showed a granuloma with foci of necrosis and scanty parasites which were not isolated on hamster inoculation. Two Case 2. Primary lesion of upper lip in 3 month old child from whom L braziliensis braziliensis was recovered. Secondary glabellar lesion evident. month old lesions were present on the right cheek and right nipple. The nipple was indurated, swollen, and painful. The mother was lactating and no biopsy or needling was permitted. She was expressing the breast. The leishmanin skin test gave a positive reaction but no circulating antibodies could be detected. Mother and child responded well to meglumine antimonate 28 mg/kg daily for 10 days, repeated on two further occasions. On follow up a year later, however, while the mother remained asymptomatic, the child's lip lesion had returned and was more extensive than before. She was given further treatment.
Comment
We have isolated L braziliensis braziliensis from 95% of our patients examined in the area.' The commonest presentation is as a single large ulcer on the lower leg.2 One third of patients with skin leishmaniasis, however, have multiple lesions. Of these 59 patients, 38 had a lesion on the leg, 18 on the trunk, 17 on the arm, and 12 on the head. We have recognised nipple leishmaniasis only in the two cases described.
Neither of the two nipple lesions ulcerated and it may be that we have missed other cases for want of specific palpation of this structure. We shall do nipple palpation in all patients with multiple skin lesions due to leishmaniasis in the future. The nipple is usually covered in our patients, and we have never seen a primary lesion. Leishmaniasis of the breast was referred to as a secondary lesion in two patients in a Mexican series, but it was not clear if the nipple was the specific site.
From the course of the disease in our two patients it is clear that the nipple lesion represented a metastasis from the site of primary 
